Norton Johna 4
4 · ELI LILLY & Co · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Norton Johna
EVP, Global Quality
Transactions
- Sale
Common Stock
[F1][F2]2024-06-03$819.38/sh−7,056$5,781,545→ 25,428 total
Holdings
- 402(indirect: By 401(k))
Common Stock
- 1,770(indirect: By 401(k))
Common Stock
[F3] - 128(indirect: by partner)
Common Stock
[F3]
Footnotes (3)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
Signature
/s/ Jonathan Groff for Johna Norton, pursuant to authorization on file|2024-06-03